Market Research Blog – Page 1359 – New Product Development

Prosthetic Heart Valve Market Poised for Significant Growth, Projected to Reach USD 27,277.6 Million by 2033 at a 7.5% of CAGR

The global prosthetic heart valve market is on a strong growth trajectory, with a projected market size of USD 13,234.9 million by the end of 2023. The industry is expected to advance significantly over the next decade, with the market anticipated to reach approximately USD 27,277.6 million by 2033. This represents a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

When considering end users, hospitals took the lead in the global prosthetic heart valve market in 2021, commanding an estimated revenue share exceeding 75%. This dominance is expected to persist throughout the forecast period

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment the growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and an increasing number of heart valve implantation procedures are other factors expected to influence the revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure-related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Segmentation highlights

The global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).

The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional market projections

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%. Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Vendor insights

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. Leading market players are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key competitors covered in terms of prosthetic heart valve market are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNovaPLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include:

product approvals and commercialisation, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

A Full Report – Overview

Key Segment

By Product Type

Mechanical Heart Valves
Mechanical Aortic Valve
Mechanical Mitral Valve
Biological/Tissue Heart Valves
Tissue Aortic Valve
Tissue Mitral Valve
Transcatheter Heart Valves
Transcatheter Aortic Valve
Transcatheter Mitral Valve

By End User

Hospitals
Ambulatory Surgery Centres

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Coronary Stents Market Is Anticipated to Reach USD 51.2 Billion by 2032, Growing at a 5.1% CAGR | FMI Research

The fight against heart disease is gaining momentum with advancements in coronary stents. The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth trajectory. This translates to a projected Compound Annual Growth Rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market was valued at an estimated USD 33.36 billion.

The increasing awareness of the manifold benefits associated with stenting procedures, such as the significant enhancement of blood flow and protection against further damage to the heart muscle, is a pivotal driver of market expansion. Stenting also offers a means to ameliorate heart disease symptoms, including angina and shortness of breath, ultimately reducing the necessity for coronary bypass surgery. Consequently, both surgeons and patients, given its minimally invasive nature and relatively brief post-operative recovery period, favor stenting.

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.

Coronary Stents Market Key Takeaways:

Rising awareness of the benefits associated with stenting will strengthen market prospects.
Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
Growing cases of coronary artery diseases propel the coronary stent market in the United States.
Favorable government support for the healthcare sector will present new market opportunities in China.

Coronary Stents Market Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgrades and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Market Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Key Segments Covered in the Coronary Stents Market Analysis

By Product:

Drug Eluting Stent (DES)
Bare Metal Stent (BMS)
Bioresorbable Vascular Stent (BVS)

By Raw Material:

Cobalt-Chromium
Stainless Steel
Platinum – Chromium
Nickel – Titanium
Polymer

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Sales of Syringes and Needles in GCC Expected to Reach USD 1,164.90 Million by 2034, Driven by a 5.40% CAGR

The sales of syringes and needles in (GCC) region are set to experience significant growth, with projections indicating a rise at a Compound Annual Growth Rate (CAGR) of 5.40% through 2034. The market for syringes and needles in the GCC is anticipated to surpass USD 688.5 million in 2024 and is expected to reach approximately USD 1,164.90 million by 2034.

This robust growth is driven by increasing healthcare needs, rising patient volumes, and the expanding use of syringes and needles in various medical procedures. The demand for these essential medical supplies is fueled by advancements in healthcare infrastructure and a heightened focus on effective and safe medical treatments.

Digital Dentistry: The Future

In the year 2019, the IDC (International Dental Show) was attended by the Institute of Digital Dentistry in Cologne, Germany. It threw light on the ways dentistry has evolved in the form of 3D printers, CAD materials, milling machines, and intraoral scanners. The institute otherwise provides training and CAD/CAM courses in New Zealand as well as online to keep the dentists and course attendees updated about clinical relevance and implementation of digitization by the key market players.

Digital Expansion: Key to Growth

As stated above, the market players are looking to provide digital imaging solutions to cater to the increasing number of patients with dental ailments. Some of the measures taken in this regard include:

In Jun 2020, Level Equity-backed Planet DDS signed an agreement to acquire Apteryx Imaging, a Canada-based publicly traded company to explore a wider arena in terms of geography
DENTSPLY Sirona Inc., in Oct 2019, launched 2 intraoral sensors (Xios AE and Schick AE) and 3D/2D imaging systems (Orthophos E, Orthophos SL 3D, and Orthophos S 3D)
In Oct 2019, Envista Holdings Corporation entered into a partnership with TeamSmile programs all through the US for propagating the use of KaVo SMARTmatic and KaVo MASTERtorque LUX M8900L

Key Takeaways of Dental Imaging Equipment Market

The market is expected to grow steadily, reaching a value of USD 4.45 billion by 2034.
Increased focus on oral health and preventive care is driving demand for dental imaging equipment.
Patients are seeking earlier diagnosis and treatment, prompting dental practices to invest in advanced imaging technology.
Manufacturers are innovating with touchless features, remote operation, and improved disinfection to meet post-pandemic needs.

“The players are shifting their gears towards digital imaging. This upgradation is expected to shape the Global Dental Imaging Equipment Industry.” says an FMI Analyst.

More Valuable Insights on Dental Imaging Equipment Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the dental imaging equipment market based on product type, (Intraoral X-ray Systems, Intraoral Plate Scanners, Intraoral Sensors, Intraoral Phosphor Storage Plates, Extraoral X-ray Systems, Cone-Beam Computed Tomography (CBCT) Imaging, Intraoral Cameras), by End User (Hospitals, Ambulatory Surgical Centers, Independent Dental Clinics, Forensic Laboratories), across seven major regions.

Leading Players in the Dental Imaging Equipment Market

The dental imaging equipment market is onto the digital spree. Digital imaging systems are being provided by the key players to cater to the increasing number of patients throughout. At the same time, AI is being tried out as an effective tool for dental digital solutions.

In line with the above-mentioned developments, twin robotic X-Ray system from Siemens provides a combination of 2D X-Rays with fluoroscopy along with 3D imaging.

The key players in dental imaging equipment including the ones mentioned above are:

Envista Holdings Corporation
Dentsply Sirona
Carestream Dental, LLC
Danaher Corporation
Acteon Group
Planmeca Oy

Dental Imaging Equipment Market: Segmentation The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. Product Type

Intraoral X-ray Systems
- Wall/Floor Mounted Intraoral X-ray Systems
- Hand-Held Intraoral X-ray Systems
Intraoral Plate Scanner
Intraoral Sensors
Intraoral Phosphor Storage Plates
Extraoral X-ray Systems
- Panoramic X-rays Systems
- Cephalometric Projections Systems
Cone-Beam Computed Tomography (CBCT) Imaging
Intraoral Cameras

End Users

Hospitals
Independent Dental Clinics
Ambulatory Surgical Centres
Forensic Laboratories

A Full Report – Overview

Key Segments :

By Product:

Oral
Hypodermic
- Standard
- Special Purpose
  - Insulin
  - Tuberculin
  - Other Special Purpose
  - Angiographic

By Usability:

Disposable
Reusable

By Material:

Glass
Polymer

By End User:

Hospital
Blood Collection Center
Diabetic Care Center
Veterinary Care Center
Others

By Country:

Kingdom of Saudi Arabia (KSA)
United Arab Emirates (UAE)
Qatar
Bahrain
Oman
Kuwait

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Dental Imaging Equipment Market Set to Reach USD 4,450.8 Million by 2034 at a 3.30% of CAGR

The global Dental Imaging Equipment Market is flashing a healthy smile, experiencing robust growth fueled by a surge in oral health awareness. According to market projections, the market is set to skyrocket from USD 3,216.9 million in 2024 to a staggering USD 4,450.8 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 3.30%.

Digital Dentistry: The Future

Digital Expansion: Key to Growth

In Jun 2020, Level Equity-backed Planet DDS signed an agreement to acquire Apteryx Imaging, a Canada-based publicly traded company to explore a wider arena in terms of geography
DENTSPLY Sirona Inc., in Oct 2019, launched 2 intraoral sensors (Xios AE and Schick AE) and 3D/2D imaging systems (Orthophos E, Orthophos SL 3D, and Orthophos S 3D)
In Oct 2019, Envista Holdings Corporation entered into a partnership with TeamSmile programs all through the US for propagating the use of KaVo SMARTmatic and KaVo MASTERtorque LUX M8900L

Key Takeaways of Dental Imaging Equipment Market

The market is expected to grow steadily, reaching a value of USD 4.45 billion by 2034.
Increased focus on oral health and preventive care is driving demand for dental imaging equipment.
Patients are seeking earlier diagnosis and treatment, prompting dental practices to invest in advanced imaging technology.
Manufacturers are innovating with touchless features, remote operation, and improved disinfection to meet post-pandemic needs.

“The players are shifting their gears towards digital imaging. This upgradation is expected to shape the Global Dental Imaging Equipment Industry.” says an FMI Analyst.

More Valuable Insights on Dental Imaging Equipment Market

Leading Players in the Dental Imaging Equipment Market

In line with the above-mentioned developments, twin robotic X-Ray system from Siemens provides a combination of 2D X-Rays with fluoroscopy along with 3D imaging.

The key players in dental imaging equipment including the ones mentioned above are:

Envista Holdings Corporation
Dentsply Sirona
Carestream Dental, LLC
Danaher Corporation
Acteon Group
Planmeca Oy

*The list is not exhaustive and is only for representational purposes. Full competitive intelligence with SWOT analysis is available in the report

Intraoral X-ray Systems
- Wall/Floor Mounted Intraoral X-ray Systems
- Hand-Held Intraoral X-ray Systems
Intraoral Plate Scanner
Intraoral Sensors
Intraoral Phosphor Storage Plates
Extraoral X-ray Systems
- Panoramic X-rays Systems
- Cephalometric Projections Systems
Cone-Beam Computed Tomography (CBCT) Imaging
Intraoral Cameras

End Users

Hospitals
Independent Dental Clinics
Ambulatory Surgical Centres
Forensic Laboratories

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Regenerative Medicine Industry Set for Remarkable Growth, Projected to Reach USD 73,084.2 Million by 2033 at a 18.5% of CAGR

The Global Regenerative Medicine Industry is on track for a remarkable trajectory, with a projected market value of USD 73,084.2 million by 2033. This signifies a staggering growth rate, with the market estimated to be valued at USD 13,385.6 million in 2023. This translates to a Compound Annual Growth Rate (CAGR) of approximately 18.5% anticipated from 2023 to 2033.

Over the projection period, there will be a greater need for the regenerative medicine industry due to the global increase in the incidence and prevalence of chronic diseases like cancer, diabetes, ulcers, and cardiovascular disease.

Increasing awareness about regenerative medicines and increasing the ability of people to spend on better treatments are playing a key role in promoting the growth of the industry. The growing aging population and increased demand for regenerative medicine in treating age-related degenerative diseases are driving growth in the industry.

An increase in investment by government organizations in the development of regenerative medicine is a major factor boosting the growth of the global industry during the forecast period. The increasing demand for personalized medicines has led to the development of patient-specific therapies, driving demand in the market.

The growing technological advances in stem cell research, tissue engineering, 3D bioprinting, and gene therapy have expanded the possibilities within regenerative medicine. These technologies enable the development of more effective and targeted treatments, attracting investment and driving innovation in the field.

The rising incidences of genetic disorders such as cystic fibrosis and other rare disorders propel the growth of the regenerative medicine market, as these therapies have the potential to address the root causes of rare genetic and inherited disorders.

Global Regenerative Medicine Industry Key Takeaways:

From 2017 to 2022, the regenerative medicine industry was valued at a CAGR of 16.2%
Based on therapy type, tissue engineering segment is expected to account for a share of 43% in 2023.
Global regenerative medicine demand in Australia is predicted to account for a CAGR of 11.5% through 2033.
In the United Kingdom regenerative medicine industry is expected to account for a CAGR of 13.2% between 2023 and 2033.
China is projected to expand by a value CAGR of 27.2% between 2023 and 2033.
By 2033, the regenerative medicine industry in India is anticipated to record a CAGR of 15.5% during the forecast period.

“The increasing awareness of consumers, growing prevalence of chronic diseases, and rising needs for personalized medicine solutions are anticipated to drive the industry growth during the forecast period,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI) analyst.

Competitive Landscape from the Global Regenerative Medicine Industry:

The global regenerative medicine industry is highly fragmented due to the presence of several international as well as regional players. Key players in the global industry of regenerative medicine are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies.

In February 2020, Stryker Corporation acquired Wright Medical to expand its product portfolio.
In October 2020, Thermo Fisher Scientific, Inc. launched the Gibco CTS Rotea Counterflow Centrifugation System, a closed cell therapy processing system for developing and manufacturing scalable and cost-effective cell therapy.
Roche has invested in regenerative medicine through its subsidiary Genentech. They have been involved in stem cell research and regenerative approaches for neurological disorders. The company is exploring personalized medicine options using regenerative techniques.

Global Regenerative Medicine Industry Segmentation:

By Therapy type:

Cell Therapy
- Autologous Cell Therapy
- Allogenic Cell Therapy
Stem Cell Therapy
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Tissue-engineering
Gene Therapy

By Application:

Wound Care
Musculoskeletal
Oncology
Dental
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Inflammatory & Autoimmune Diseases
Other Therapeutic Applications

Author By:

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Antibody Market to Soar to USD 581.42 Billion by 2034, Reflecting a Strong CAGR of 8.1%

The global antibody market is on a remarkable growth trajectory, with an estimated valuation of USD 266.83 billion in 2024. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 8.1% from 2024 to 2033, reaching approximately USD 581.42 billion by the end of the forecast period. This growth represents an absolute increase of USD 315 billion in market value.
The significant expansion of the antibody market is driven by the increasing demand for effective therapeutic solutions across various medical conditions, ongoing advancements in biotechnology, and the rising prevalence of chronic diseases. Antibodies, being critical components in the treatment of numerous illnesses, are seeing heightened investment and innovation, propelling market growth.

Advancements in biotechnology, an increase in the prevalence of chronic illnesses, and the rising demand for targeted therapies are key factors propelling the antibody market forward. Additionally, significant investments in research and development are leading to the innovation of new and more effective antibody-based treatments, further fueling market growth.

Antibodies are vital in the domains of medicine, pharmacology, research applications, and diagnostics. This is shown by the market’s expected growth. As an essential component of the immune system’s fight against infections, antibodies—also referred to as immunoglobulins—help prevent infectious diseases, autoimmune illnesses, and cancer.

Focus on High-Quality and Specificity

As research becomes increasingly sophisticated, the need for high-quality and highly specific research antibodies becomes paramount. This ensures accurate and reliable results, ultimately contributing to breakthroughs in scientific exploration and medical advancements.

Proteomics, genomics, and biotechnology developments have propelled the market’s substantial expansion for research antibodies. There are several different types of antibodies available on the market, such as recombinant, polyclonal, and monoclonal antibodies, all of which are designed to target different biomarkers and antigens. These antibodies are used by researchers in academic institutions, pharmaceutical companies, and biotechnology businesses to decipher intricate biological processes, identify disease pathways, and confirm possible therapeutic targets.

Key Takeaways: Research Antibodies Market:

The research antibodies market plays a pivotal role in advancing scientific discoveries and medical breakthroughs across various fields of study. Here are the key takeaways that highlight the trends, challenges, and opportunities within the research antibodies market:

Market Growth and Importance:
- The research antibodies market is witnessing significant growth due to increasing demand for targeted and personalized medicine, as well as the expansion of life sciences research.
- Research antibodies are crucial tools for identifying and studying specific proteins, biomarkers, and cellular components, enabling researchers to unravel complex biological processes.
Monoclonal vs. Polyclonal Antibodies:
- Monoclonal antibodies (mAbs) offer high specificity and consistency, making them preferred choices for diagnostic and therapeutic applications.
- Polyclonal antibodies (pAbs) have broader binding capabilities and are often used for detecting multiple epitopes.
Application Diversity:
- Research antibodies find applications in various domains, including cancer research, neuroscience, immunology, stem cell research, and infectious diseases.
- They aid in studying disease mechanisms, validating drug targets, and monitoring treatment responses.
Technological Advancements:
- The development of recombinant antibody technologies has led to the generation of recombinant antibodies with improved specificity and reduced batch-to-batch variability.
- Single-cell antibody sequencing and phage display techniques are enhancing antibody discovery and customization.
Quality and Reproducibility Concerns:
- Ensuring antibody specificity, reproducibility, and validation has been a challenge, leading to concerns about irreproducible results in research.
- Initiatives like the “Reproducibility Crisis” movement emphasize the importance of transparent reporting and validation of research antibodies.
Rising Industry Regulations:
- Regulatory bodies are emphasizing the need for rigorous validation of research antibodies to ensure reliable and accurate experimental outcomes.
- Guidelines for antibody validation, such as those provided by the International Working Group on Antibody Validation (IWGAV), are gaining traction.

Key Companies Profiled:

Abcam Plc
Agilent Technologies
Bio-rad Laboratories
Becton Dickinson & Company
Cell Signalling Technology, Inc.
F. Hoffmann La Roche Ltd.
Lonza Group
Merck Millipore
Perkinelmer Inc.
Thermo Fisher Scientific, Inc.

A Full Report – Overview

Market Segments Covered in Research Antibodies Market Analysis:

By Product Type:

Primary
Secondary

By Type:

Monoclonal Antibodies
Polyclonal Antibodies

By Technology:

Immunohistochemistry
Immunofluorescence
Western Blotting
Flow Cytometry
Immunoprecipitation
ELISA
Other Technologies

By Source:

Mouse
Rabbit
Goat
Other Sources

By Region:

North America
Latin America
Europe
APAC
MEA

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Urinary Tract Infection (UTI) Treatment Market Expected to Reach USD 13,617.4 Million by 2034 at a 1.9% of CAGR

The urinary tract infection (UTI) treatment market is projected to reach USD 11,244.0 million in 2024, with expectations for continued growth over the next decade. The market is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 1.9%, culminating in a valuation of approximately USD 13,617.4 million by 2034.

The steady growth of the UTI treatment market reflects an increasing focus on addressing this common infection, which affects millions of individuals worldwide. Advances in treatment options, combined with a rising awareness of UTI prevention and management, are contributing to the market’s upward trajectory.

The urinary tract infection treatment market is poised for substantial growth in the foreseeable future, attributed to factors such as hormonal changes, inadequate personal hygiene practices, catheter usage, and other contributing factors. As the prevalence of urinary tract infections rises, the market is anticipated to experience noteworthy expansion in the coming years.

The heightened occurrence of chronic kidney diseases, including conditions like bladder cancer and renal failure, has resulted in a greater utilization of catheters and other drainage devices among patients. Individuals using urinary catheters face an elevated risk of developing complicated urinary tract infections, driving the demand for UTI treatment.

Supportive government policies, initiatives, and regulations can influence the market positively by fostering research and development in the field of UTI treatment. Increased spending on healthcare infrastructure and services, both in developed and developing countries, can positively influence the UTI treatment market.

The adoption of telehealth and remote patient monitoring technologies can facilitate better management and follow-up care for individuals with UTIs. Growing awareness among patients and healthcare professionals about the importance of early detection and prompt treatment of UTIs can contribute to market growth.

Urinary Tract Infection (UTI) Treatment Market Key Takeaways

From 2019 to 2023, the urinary tract infection (UTI) treatment market was valued at a CAGR of 2.1%
Based on indication, the uncomplicated UTI segment is expected to account for a share of 76.2% in 2024.
Global urinary tract infection (UTI) treatment demand in China is predicted to account for a CAGR of 2.0% in 2024.
In the United States, the urinary tract infection (UTI) treatment industry is expected to account for a CAGR of 2.5% in 2024.
India is projected to expand by a value CAGR of 1.9% between 2024 and 2034.
The urinary tract infection (UTI) treatment market in Japan is anticipated to record a CAGR of 2.1% in 2024.

“Increased prevalence of urinary tract infections and strategic advancements in treatment options propel the growth of the urinary tract infection treatment market.” says an FMI analyst.

Urinary Tract Infection (UTI) Treatment Market Competitive Landscape

The market players are investing in ongoing research and development activities to discover and develop new and more effective UTI treatment options. This could involve the exploration of novel antibiotics, combination therapies, and innovative drug delivery methods. Expanding market presence by entering new geographic regions and enhancing distribution networks to ensure wider availability of UTI treatments.

Bristol-Myers Squibb Company focuses on the development of drugs in various therapeutic areas, including infectious diseases. They might have products related to UTI treatment.
Janssen Global Services LLC is a pharmaceutical company under the umbrella of Johnson & Johnson. They may have products related to infectious diseases, including UTI treatment.
Lupin is an Indian multinational pharmaceutical company. They might have a range of pharmaceutical products, including those related to infectious diseases.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global urinary tract infection (UTI) treatment market, providing historical data from 2019 to 2023 and forecast statistics between 2024 and 2034.

To understand opportunities in the urinary tract infection (UTI) treatment industry, the industry is segmented based on Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole, Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Others) By Indication(Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection) By Distribution Channel(Hospital Pharmacies, Gynecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores) Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

Key Players operating in the Urinary Tract Infection (UTI) Treatment Market are

Allergan
Bayer AG
Pfizer, Inc.
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Janssen Global Services, LLC
Lupin Ltd
Merck & Co., Inc.
Almirall, S.A
Dr. Reddy’s Laboratories Ltd.

A Full Report – Overview

Urinary Tract Infection (UTI) Treatment Market – Key Segments

By Drug Class:

Penicillin & Combinations
Quinolones
Cephalosporin
Aminoglycoside Antibiotics
Sulphonamides (Sulfamethoxazole, Trimethoprim)
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Others

By Indication:

Complicated
Uncomplicated

By Distribution Channel:

Hospital Pharmacies
Gynecology and Urology Clinics
Drug Stores
Retail Pharmacies
Online Drug Stores

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide.

With a repertoire of over 100+ reports and 1 billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Wearable Medical Device Market Set for Significant Growth, Projected to Reach USD 84.8 Billion by 2034 at a 8.2% of CAGR

The wearable medical device market is poised for remarkable growth, with anticipated sales of USD 38.5 billion in 2024. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 8.2% from 2024 to 2034, reaching an estimated USD 84.8 billion by the end of the forecast period.

Wearable medical devices, which encompass a range of technologies designed for continuous health monitoring and management, are increasingly becoming integral to modern healthcare. These devices offer users the ability to track vital signs, manage chronic conditions, and improve overall health outcomes with real-time data and personalized insights.

Wearable medical devices are emerging as a pivotal solution to address these challenges, offering continuous monitoring and real-time data collection. This trend is further accelerated by the active encouragement of routine diagnosis by regional and national healthcare agencies through awareness programs and various campaigns. These initiatives are fostering heightened awareness among the masses regarding the benefits of wearable medical devices for monitoring and diagnosing vital signs.

Key Takeaways from the Wearable Medical Device Market Report

The wearable medical device market achieved a market size of US$ 36,604.3 million in 2023. During the historical period, the market registered a CAGR of 7%.
By product, the wearable therapeutic medical device segment is estimated to acquire a value share of 55% in 2024.
Based on the application, the home healthcare segment is anticipated to obtain a market share of 63% in 2024.
The wearable medical device industry in the United States is expected to expand at a CAGR of 5% through 2034.
The wearable medical device market in France is projected to register a CAGR of 8% from 2024 to 2034.
The wearable medical device market in India is estimated to record a staggering CAGR of 40% over the forecast period.
The market in Singapore is projected to grow at a CAGR of 10% through 2034.

“Continuous advancements and release of upgraded wearable medical devices by leading players are expected to be a go-to-market strategy of leading players. Additionally, players are expected to explore the potential of wearable medical devices in various new segments,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Competitive Landscape in the Wearable Medical Device Market

Market players are developing advanced wearables and exploring new application cases for wearable medical devices, which is contributing to market growth. The industry participants are acquiring firms with complementary technologies and collaborating with other healthcare institutions, technology providers, and pharmaceutical firms to expand their distribution channels, leverage expertise, and develop integrated solutions.

Players are further emphasizing privacy and data security and prioritizing user-friendly designs to boost user adoption and compliance. Industry participants are getting involved in targeted marketing campaigns toward certain healthcare professionals and patient segments to elevate brand recognition and drive device adoption.

Recent Developments in the Wearable Medical Device Market

In July 2023, Dexcom, a developer of constant glucose monitors, revealed that it is making a Type 2 diabetes monitor for patients who don’t require insulin. The company also offers a cash-pay choice for patients not secured by health insurers and Medicare.

In July 2023, Samsung announced that it is gearing up to launch the ‘Galaxy Ring’ equipped with smart health features in 2024. For the success of its recent wearable endeavor, the Korean tech giant is collaborating with international as well as domestic component manufacturers.

Manufacturers of the Wearable Medical Device Market

Medtronic plc
Siemens AG
Fitbit Inc.
Bayer AG
Panasonic Corporation
Animas Corporation – Johnson and Johnson
Smiths Medical – A Smiths Group Company
Koninklijke Philips N.V.
Owlet Baby Care
OMRON Corporation
Hoffmann-La Roche Ltd
Rest Devices Inc.
Others

A Full Report – Overview

Wearable Medical Device Market Segmentation

By Product:

Wearable Monitoring and Diagnostic Devices
Fetal and Obstetric Devices
- Wearable Foetal Monitors
- Infant Motion Sensing Monitors
Continuous Glucose Monitoring Devices
Cardiac Monitoring Devices
- Wearable Heart Rate Monitors
- Wearable Pulse Oximeters
- Wearable Blood Pressure Monitors
Wearable Therapeutic Medical Device
Hearing Aid
Insulin Pump
Respiratory Therapy Devices
- Sleep Apnea Devices
- Non-invasive Ventilation
Health and Fitness Devices

By Application:

Patient Monitoring
Home Healthcare
Health and Fitness

By Distribution Channel:

Hospital Pharmacies
Clinics
Online Channels
Hypermarkets

By Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fertility and Pregnancy Rapid Test Kit Market Poised for Robust Growth, Expected to Reach USD 1,609.1 Million by 2033 at a 5% of CAGR

The fertility and pregnancy rapid test kit market, valued at USD 948.3 million in 2022, is set for continued growth, with expectations to reach USD 990.4 million by the end of 2023. Over the forecast period, the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 5%, ultimately achieving a valuation of approximately USD 1,609.1 million by 2033.

The growth in the fertility and pregnancy rapid test kit market is driven by increasing consumer demand for convenient, at-home testing solutions. Rapid test kits offer users a quick and reliable way to monitor fertility and confirm pregnancy, contributing to their rising popularity among consumers seeking efficient and private testing options.

Due to shifts in healthcare choices and increased awareness worldwide, the market for fertility and pregnancy test kits is expanding gradually but steadily. These kits give consumers the privacy, simplicity of use, and clarity they need to make informed decisions about their reproductive health.

Key Takeaways from the Market Analysis

The fertility and pregnancy rapid test kit market developed at a 4% CAGR throughout the historical period.
The market in the United States is expected to increase at a 5.2% CAGR over the forecast period.
From 2023 to 2033, the fertility and pregnancy rapid test kit market in China is set to garner a 6% CAGR.
The market in France is expected to increase at a 4.2% CAGR from 2023 to 2033.
The fertility and pregnancy rapid test kit market in Japan is predicted to flourish at a 4.7% CAGR over the projected period.
The market in the United Kingdom is forecast to advance at a 4.9% CAGR over the projected period.
The pregnancy rapid test kit segment is anticipated to capture a CAGR of 4.5% through 2033.
The hCG urine test segment is predicted to secure a CAGR of 6.2% from 2023 to 2033.

“The availability of at-home self-test kits, successful early pregnancy detection, and the affordability of fertility and pregnancy rapid test kit are additional benefits contributing to the overall growth of the market,”- remarks an FMI analyst.

Competitive Landscape

Manufacturers are evolving their product portfolios of fertility and pregnancy rapid test kit by launching new products. This covers various test sensitivity levels, formats (e.g., blood, digital, urine-based), and packaging choices (e.g., single-use kits, multi-pack alternatives).

Manufacturers may increase revenue and sales by catering to various consumer requirements and tastes through a wide range of products.

Prominent players in the fertility and pregnancy rapid test kit market are

Alere Inc.
Quidel Corporation
Prestige Brands Holdings, Inc.
Church & Dwight Co., Inc.
bioMérieux SA
Geratherm Medical AG
Abbott Laboratories
Procter & Gamble Co.
DCC Plc.
Swiss Precision Diagnostics GmbH

Key Developments

In 2022, to help individuals throughout their whole reproductive journey, Kindbody launched the Kind at Home fertility kits, its consumer goods business. Their first offering is an easy-to-use at-home fertility hormone test for both men and women.

With the Kind at Home fertility test kit, customers may conveniently obtain detailed information regarding their fertility status from the comfort of their own homes. Kindbody physicians make individualized suggestions that can be brought to the online or in-person clinic consultation with the patients.

PregaScreen is a home pregnancy test kit that was introduced by Mylab Discovery Solutions. With this, the business has officially entered the female healthcare market. The kit is available for purchase over the counter at neighborhood pharmacies around the nation. It yields accurate findings in a matter of minutes. Pregnancy stick devices and droppers are included with every package.
In 2023, Proov and 2San, a reputable global leader in self-diagnostic testing, teamed to provide the unique, simple-to-use, at-home fertility tests of Proove in a few Midwest Hy-Vee locations. With its four products—Reserve (follicle stimulating hormone), Predict (luteinizing hormone), Confirm (PdG), and Check (human chorionic gonadotropin)—their range of tests provides a thorough evaluation of fertility at an affordable price.

Segmentation Analysis of the Fertility and Pregnancy Rapid Test Kit Market:

By Product:

Pregnancy Rapid Tests
- Line Indicator devices
  - Strips/Dip Sticks
  - Mid-Stream
  - Cassettes
- Digital
Fertility Rapid Tests
- Line Indicator
- Digital

By Test Type:

LH Urine
FSH Urine
hCG Blood
hCG Urine

By Distribution channel:

Pharmacy
Drugstore
Gynecology/Fertility Clinics
e-commerce
Hypermarkets & Supermarkets

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East & Africa

Examine an Enlightening – Report

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI Analysis States Global District Cooling Market Revenue Share Anticipated to Surge Past USD 63.2 Billion Mark by 2033, Growing at 8.0% CAGR

The district cooling market is poised for substantial growth, projected to surge from USD 29.2 billion in 2023 to a remarkable USD 63.2 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.0% from 2023 to 2033.

The escalating demand for district cooling solutions is closely intertwined with the pressing environmental challenges posed by global warming. Observable impacts of climate change, such as earlier tree blooming, premature ice melting on rivers and lakes, and rapid glacier recession, underscore the urgent need for sustainable cooling technologies.

The rise in carbon dioxide (CO2) concentrations in the atmosphere, attributed largely to the widespread use of fossil fuels such as coal and oil, exacerbates the climate crisis. As nations strive to mitigate the adverse effects of greenhouse gas emissions, the adoption of district cooling systems emerges as a vital strategy to promote energy efficiency and reduce carbon footprints in urban environments.

Demand Factors:

The demand for cooling is particularly pronounced in tropical and hot climate zones, where air conditioner ownership is on the rise, as reported by the International Energy Agency (IEA). Notably, the Middle East stands out as one of the most advanced markets for district cooling systems.

In regions characterized by hot temperatures, there exists a pressing need for effective cooling solutions to ensure comfort, particularly during the scorching summer months.

With summertime temperatures soaring above 50 degrees Celsius in the Middle East, cooling becomes a paramount concern for inhabitants of this region. According to the Dubai Electricity and Water Authority, there is a staggering 40% surge in electricity demand, primarily for cooling purposes, during the scorching midday hours of summer. Cooling alone accounts for a substantial 70% of the region’s total energy requirement during the summer season.

District cooling emerges as a viable solution to address the energy-intensive nature of traditional cooling systems, offering efficient cooling capabilities. The IEA highlights a 60% increase in global energy demand for space cooling between 2000 and 2010. District cooling systems present an environmentally-friendly alternative to conventional air conditioning methods, helping to mitigate the use of environmentally harmful refrigerants like hydrochlorofluorocarbons (HCFCs) and hydrofluorocarbons (HFCs).

Key Players:

National Central Cooling Company PJSC
Emirates District Cooling
LLC (EMICOOL)
Shinryo Corporation
ADC Energy Systems LLC
Keppel DCHS PTE LTD
LOGSTOTR A/S
Ramboll Group A/S
SIEMENS AG
Stellar Energy

Key Segments Covered:

By Production Technique:

Free Cooling
Absorption Cooling
Electric Chiller

By Application:

Residential
Commercial
Industrial

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East and Africa

Read Report Details for FREE!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube